Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 4
2005 2
2006 1
2007 2
2008 1
2009 1
2010 1
2011 4
2012 6
2013 3
2014 5
2015 3
2017 2
2018 1
2019 1
2020 3
2021 5
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial.
Trigo J, Subbiah V, Besse B, Moreno V, López R, Sala MA, Peters S, Ponce S, Fernández C, Alfaro V, Gómez J, Kahatt C, Zeaiter A, Zaman K, Boni V, Arrondeau J, Martínez M, Delord JP, Awada A, Kristeleit R, Olmedo ME, Wannesson L, Valdivia J, Rubio MJ, Anton A, Sarantopoulos J, Chawla SP, Mosquera-Martinez J, D'Arcangelo M, Santoro A, Villalobos VM, Sands J, Paz-Ares L. Trigo J, et al. Among authors: alfaro v. Lancet Oncol. 2020 May;21(5):645-654. doi: 10.1016/S1470-2045(20)30068-1. Epub 2020 Mar 27. Lancet Oncol. 2020. PMID: 32224306 Clinical Trial.
Lurbinectedin in the treatment of relapsed small cell lung cancer.
Baena J, Modrego A, Zeaiter A, Kahatt C, Alfaro V, Jimenez-Aguilar E, Mazarico JM, Paz-Ares L. Baena J, et al. Among authors: alfaro v. Future Oncol. 2021 Jun;17(18):2279-2289. doi: 10.2217/fon-2020-1212. Epub 2021 Mar 19. Future Oncol. 2021. PMID: 33736462 Review.
Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study.
Kristeleit R, Leary A, Delord JP, Moreno V, Oaknin A, Castellano D, Shappiro GI, Fernández C, Kahatt C, Alfaro V, Siguero M, Rueda D, Zeaiter A, Awada A, Santaballa A, Zaman K, Sehouli J, Subbiah V. Kristeleit R, et al. Among authors: alfaro v. Invest New Drugs. 2023 Oct;41(5):677-687. doi: 10.1007/s10637-023-01383-2. Epub 2023 Aug 9. Invest New Drugs. 2023. PMID: 37556023 Free PMC article. Clinical Trial.
Lurbinectedin in patients with small cell lung cancer with chemotherapy-free interval ≥30 days and without central nervous metastases.
Peters S, Trigo J, Besse B, Moreno V, Navarro A, Eugenia Olmedo M, Paz-Ares L, Grohé C, Antonio Lopez-Vilariño J, Fernández C, Kahatt C, Alfaro V, Nieto A, Zeaiter A, Subbiah V. Peters S, et al. Among authors: alfaro v. Lung Cancer. 2024 Feb;188:107448. doi: 10.1016/j.lungcan.2023.107448. Epub 2023 Dec 27. Lung Cancer. 2024. PMID: 38198859 Free article. Clinical Trial.
Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study.
Longo-Muñoz F, Castellano D, Alexandre J, Chawla SP, Fernández C, Kahatt C, Alfaro V, Siguero M, Zeaiter A, Moreno V, Sanz-García E, Awada A, Santaballa A, Subbiah V. Longo-Muñoz F, et al. Among authors: alfaro v. Eur J Cancer. 2022 Sep;172:340-348. doi: 10.1016/j.ejca.2022.06.024. Epub 2022 Jul 10. Eur J Cancer. 2022. PMID: 35830841 Free article. Clinical Trial.
[Encore abstracts in medical/scientific meetings].
Alfaro V. Alfaro V. Med Clin (Barc). 2015 May 21;144(10):477-8. doi: 10.1016/j.medcli.2014.06.008. Epub 2014 Sep 3. Med Clin (Barc). 2015. PMID: 25192580 Spanish. No abstract available.
Lipocalin-2-induced renal regeneration depends on cytokines.
Vinuesa E, Sola A, Jung M, Alfaro V, Hotter G. Vinuesa E, et al. Among authors: alfaro v. Am J Physiol Renal Physiol. 2008 Nov;295(5):F1554-62. doi: 10.1152/ajprenal.90250.2008. Epub 2008 Sep 24. Am J Physiol Renal Physiol. 2008. PMID: 18815220 Free article.
44 results